International Journal of Clinical Pharmacy

, Volume 34, Issue 2, pp 330–341 | Cite as

Fitness to practise in pharmacy: a study of impairment in professional practice

  • Annim Mohammad
  • Jane R. Hanrahan
  • Erica Sainsbury
  • Betty B. ChaarEmail author
Research Article


Objective To explore the opinions and knowledge of Australian pharmacists about impairment in the profession, and their awareness of new legislation regarding impairment and mandatory reporting. Setting Pharmacy practice in Australia. Method Pharmacists’ opinions and knowledge were explored using a purposively designed, de-identified survey distributed by an intermediate mailing house to randomly selected pharmacists registered with the Pharmacy Board. Descriptive statistics and thematic analyses were conducted on the data. Key Outcome Measures This being an explorative study, we analysed various items using standard statistical methods and qualitative thematic analysis for responses to open-ended questions. Results Responses from 370 registered pharmacists were obtained. Of these, nearly 60% were not confident in their knowledge of legislation relating to impairment. The vast majority stated they would consider reporting an impaired colleague in principle, but only after consulting the colleague. Older pharmacists demonstrated increased awareness of new legislation; this was accompanied however, by a marked decrease in confidence regarding knowledge about impairment. Thematic analysis of the qualitative data revealed four main themes: (1) perception of impairment and support systems available (2) stigma related to implications of impairment and whistle-blowing (3) factors affecting reporting of impairment and (4) management of impairment. Conclusion Australian pharmacists in this study recognised the importance of the issue of impairment, but appeared to lack confidence and/or awareness of legislative requirements regarding impairment in the profession. There is a need for educative programs and accessible, profession-specific rehabilitative programs to be instigated for management of impairment in the profession of pharmacy in Australia.


Fitness to practise Impairment Legislation Pharmacy practice Pharmacists Practice support Australia 



We are grateful for the contribution of participating pharmacists in NSW, Australia.


This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Conflicts of interest

No conflict of interest declared.


  1. 1.
    Shaw D. Ethics, professionalism and fitness to practice: three concepts, not one. Dent J. 2009;207(2):59–62.CrossRefGoogle Scholar
  2. 2.
    Pharmacy Board of Australia (2010). Pharmacy Board of Australia. Accessed 5 Nov 2010.
  3. 3.
    Brown SD, Goske MJ, Johnson CM. Beyond substance abuse: stress, burnout and depression as causes of physician impairment and disruptive behaviour. J Am Coll Radiol. 2009;6(7):479–85.PubMedCrossRefGoogle Scholar
  4. 4.
    Lapane KL, Hughes CM. Job satisfaction and stress among pharmacists in the long term care sector. Consult Pharm. 2006;21(4):287–92.PubMedCrossRefGoogle Scholar
  5. 5.
    Long MW, Cassidy BA, Sucher M, Stoehr JD. Prevention of relapse in the recovery of Arizona health care providers. J Addict Dis. 2006;25(1):65–72.PubMedCrossRefGoogle Scholar
  6. 6.
    McAuliffe WE. Non therapeutic opiate addiction in health professionals: a new form of impairment. Am J Drug Alcohol Abuse. 1984;10(1):1–22.PubMedCrossRefGoogle Scholar
  7. 7.
    Pooler D, Sheheen F, Davidson J. Professional impairment: a history and one states response. J Addict Dis. 2009;28:113–23.PubMedCrossRefGoogle Scholar
  8. 8.
    Breen K. Doctors who self-administer drugs of dependence. Med J of Aust. 1998;169:404–5.Google Scholar
  9. 9.
    Wilhelm KA, Reid AM. Critical decision points in the management of impaired doctors: the NSW medical Board program. Med J Aust. 2004;181(7):372–5.PubMedGoogle Scholar
  10. 10.
    Drug and Alcohol Services South Australia (2001). Alcohol and drug use among nurses: Guidelines for response in the workplace. Accessed 9 Dec 2011.
  11. 11.
    Bachman J, Cusack L. International perspectives. J Addict Nurs. 2003;14:157–8.CrossRefGoogle Scholar
  12. 12.
    Kenna GA, Wood MD. Prevalence of substance use by pharmacists and other health professionals. J Am Pharm Assoc. 2004;44(6):684–93.CrossRefGoogle Scholar
  13. 13.
    Dabney D. Onset of illegal use of mind-altering or potentially addictive prescription drugs among pharmacists. J Am Pharm Assoc. 2001;41:392–400.Google Scholar
  14. 14.
    Caulfield J. Confronting an everyday malice-responding to violence in pharmacy. Aust Pharm. 2010;29:23–6.Google Scholar
  15. 15.
    Schafheutle EI, Seston EM, Hassell K. Factors influencing pharmacist performance: a review of the peer-reviewed literature. Health Policy. 2011;102:178–92.PubMedCrossRefGoogle Scholar
  16. 16.
    Australasian Legal Information Institute (2010). Pharmacy Tribunal of NSW 2009: Larden NSWPHT (25 May, 2009). Accessed 9 Dec 2011.
  17. 17.
    Australasian Legal Information Institute (2010). Health practitioner law national regulation. Accessed 9 Dec 2011.
  18. 18.
    Krejcie R, Morgans D. Determining sample size for research activities. Educ Psychol Measur. 1970;30:607–10.Google Scholar
  19. 19.
    Australian Institute of Health and Welfare (2003). Pharmacy labour force to 2001. Australian Institute of Health and Welfare, Canberra AIHW cat. no. HWL 25. (National Health Labour Force Series no. 25). Accessed Dec 2011.
  20. 20.
    Bissell L, Haberman PW, Williams RL. Pharmacists recovering from alcohol and other drug addictions: an interview study. Am Pharm 1989; NS29(6):19–30.Google Scholar
  21. 21.
    Burn J. Addiction: an occupational hazard in nursing. Am J Nurs. 2007;107(8):78–9.CrossRefGoogle Scholar
  22. 22.
    Centrella M. Physician impairment and addiction. J Addict Dis. 1994;13:91–105.PubMedCrossRefGoogle Scholar
  23. 23.
    Dunn D. Home study program: substance abuse among nurses-defining the issue. AORN J. 2005;82(4):572–602.CrossRefGoogle Scholar
  24. 24.
    Pharmaceutical Society of Australia. Pharmacist Support service. Accessed 9 Dec 2011.
  25. 25.
    Pharmacists Recovery Network (2011). State PRN information. Accessed 9 Dec 2011.
  26. 26.
    Nickel RO, Briske K. Aiding impaired pharmacists: what’s being done today? Am Pharm. 1985;25(6):40–4.Google Scholar
  27. 27.
    Bunting GA, Talbott GD. One road to recovery: the Georgia program. Am Pharm. 1985;25(6):52–4.Google Scholar
  28. 28.
    Simonsmeier LM, Fox LA. The law and the impaired pharmacist. Am Pharm. 1985;25(6):63–8.Google Scholar
  29. 29.
    Metge CJ, Brown P. Setting up a program: how one group went about it. Am Pharm. 1985;25(6):49–51.Google Scholar
  30. 30.
    McNees GE, Godwin HN. Programs for pharmacists impaired by substance abuse: A report. Am Pharm 1990; NS30(5):33–7.Google Scholar
  31. 31.
    Smith DE. A clinical approach to the impaired health professional. Int J Addict. 1985;20(5):713–22.PubMedGoogle Scholar
  32. 32.
    National Clinical Assessment Service (UK), Accessed 9 Dec 2011.
  33. 33.
    Levy S. Beware the dark side of pharmacy life. Drug topics. 2002;46(13):33–41.Google Scholar
  34. 34.
    Royal Pharmaceutical Society (2011). Support for pharmacists. Accessed 9 Dec 2011.
  35. 35.
    Harvie F. Drug addiction is a disease and even pharmacists sometimes need support. Pharm J. 2008;280:59.Google Scholar
  36. 36.
    Qualter D. Benevolent fund needs your input. Pharm J. 2008;280:255.Google Scholar
  37. 37.
    Nathan A. Who are the listening friends? Pharm J. 2002;269:367–8.Google Scholar
  38. 38.
    Nathan A. Put down the metal bar, pick up the telephone: listening friends can help. Pharm J. 2006;277:575.Google Scholar
  39. 39.
    Schattner P, Davidson S, Serry N. Doctor’s health and well-being: Taking up the challenge in Australia. Med J Aust 2004; 181(7):348–349. Editorial. Accessed 9 Dec 2011.Google Scholar
  40. 40.
    Medical Council of NSW (2010). Notifications of impaired practitioners to the Board Accessed 9 Dec 2011.
  41. 41.
    Warhaft N. The Victorian Doctor’s health program: the first three years. Med J Aust. 2004;181(7):376–9.PubMedGoogle Scholar
  42. 42.
    Victorian Doctors Health Program (2010). Victorian Doctors Health Program. Accessed 9 Dec 2011.
  43. 43.
    Doctors Health Advisory Service (2011). Doctors Health Advisory Service. Accessed 9 Dec 2011.
  44. 44.
    Nurses’ registration board of NSW. Professional conduct: a case book of disciplinary decisions relating to professional conduct matters. Sydney: South Wood press; 2001.Google Scholar
  45. 45.
    Nursing and Midwifery Health Program Victoria (2011) Accessed 9 Dec 2011.
  46. 46.
    Australian Nursing federation. Support for nurses a welcome first (VIC). Aust Nurs J 2006; 13(9):9.Google Scholar
  47. 47.
    Breier-Mackine S. Ethics connection. Gastroenterol Nurs. 2007;30(3):227–8.CrossRefGoogle Scholar
  48. 48.
    Baldisseri MR. Impaired healthcare professional. Critical Care Med. 2007;35(2):S106–16.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2012

Authors and Affiliations

  • Annim Mohammad
    • 1
  • Jane R. Hanrahan
    • 2
  • Erica Sainsbury
    • 3
  • Betty B. Chaar
    • 1
    Email author
  1. 1.Faculty of PharmacyThe University of SydneySydneyAustralia
  2. 2.Faculty of PharmacyThe University of SydneySydneyAustralia
  3. 3.Faculty of PharmacyThe University of SydneySydneyAustralia

Personalised recommendations